To include your compound in the COVID-19 Resource Center, submit it here.

BMS divests HIV pipeline to ViiV

Bristol-Myers Squibb Co. (NYSE:BMY) said it will divest its discovery-stage, preclinical and clinical HIV assets to ViiV Healthcare, an HIV-focused JV majority-owned by GlaxoSmithKline plc (LSE:GSK;

Read the full 261 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE